Almirall Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
11 Jan 2024
DUBLIN, Jan. 10, 2024 /PRNewswire/ -- The "Almirall - Digital Transformation Strategies" company profile has been added to
ResearchAndMarkets.com's offering.
This report provides insights into Almirall's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Almirall is a global biopharmaceutical company specializing in dermatology. The company develops and commercializes solutions for the treatment of a variety of dermatological diseases such as acne, atopic dermatitis, actinic keratosis, and psoriasis among others.
Some of the company's key products are Ilumetri (for moderate-to-severe plaque psoriasis), Wynora cream (for mild-to-moderate plaque psoriasis), Skilarence (for moderate-to-severe plaque psoriasis), Seysara (for acne), Ciclopoli (for onychomycosis), and Klisyri, Actikerall, and Solaraze (for actinic keratosis).
The company also produces medicines for the neurological, gastric, and cardiac diseases. The company's key dermatological products have been used by 324,000 people since their launches.
Scope
Almirall is leveraging several emerging technologies to quickly discover drugs, drive sales, streamline production, expand market presence and help patients recover quickly. Cloud, AI, and digital therapeutics are among the technologies the company is focusing on.
Almirall launched its dermatology digital health accelerator, Digital Garden, in 2020 to support startups that are focused on developing technology-based services and solutions for various dermatological diseases.
Reasons to Buy
Gain insights into Almirall's technology initiatives.
Gain insights into its digital strategies and innovation initiatives.
Gain insights into its technology themes under focus.
Gain insights into its various technology launches and partnerships.
Key Topics Covered:
Overview
Digital Transformation Strategy
Accelerators, Incubators, and Other Innovation Programs
Technology Focus
Technology Initiatives
Partnership Network Map
ICT Budget and Contracts
Key Executives
A selection of companies mentioned in this report includes
NTT Data
Clariba
For more information about this company profile visit https://www.researchandmarkets.com/r/mi4ang
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.